Application 213761
- Type
- ANDA
- Sponsor
- QUAGEN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OXYCODONE HYDROCHLORIDE | OXYCODONE HYDROCHLORIDE | SOLUTION;ORAL | 5MG/5ML | No | No |
| 002 | OXYCODONE HYDROCHLORIDE | OXYCODONE HYDROCHLORIDE | SOLUTION;ORAL | 100MG/5ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 70752-136 | OXYCODONE HYDROCHLORIDE | OXYCODONE HYDROCHLORIDE | QUAGEN PHARMACEUTICALS LLC | ANDA | Current |
| 70752-136 | OXYCODONE HYDROCHLORIDE | OXYCODONE HYDROCHLORIDE | QUAGEN PHARMACEUTICALS LLC | ANDA | Current |
| 70752-137 | OXYCODONE HYDROCHLORIDE | OXYCODONE HYDROCHLORIDE | QUAGEN PHARMACEUTICALS LLC | ANDA | Current |
| 70752-137 | OXYCODONE HYDROCHLORIDE | OXYCODONE HYDROCHLORIDE | QUAGEN PHARMACEUTICALS LLC | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 76474 | ORIG | 2023-11-07 |